Forvis Wealth Advisors, LLC Biogen Inc. Transaction History

Forvis Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$259.0 - $414.71 $283,087 - $453,278	-1,093 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$242.95 - $284.63 $89,405 - $104,743	-368 Reduced 25.19%	1,093 $306,000
Q4 2020 Jan 22, 2021	BUY	$236.26 - $355.63 $148,135 - $222,980	627 Added 75.18%	1,461 $358,000
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $220,818 - $254,962	834 New	834 $237,000
Q2 2020 Jul 15, 2020	SELL	$258.66 - $342.55 $186,752 - $247,321	-722 Closed	0 $0
Q1 2020 Apr 10, 2020	SELL	$268.85 - $341.04 $3,226 - $4,092	-12 Reduced 1.63%	722 $228,000
Q4 2019 Jan 13, 2020	BUY	$220.06 - $304.07 $161,524 - $223,187	734 New	734 $218,000
Q4 2018 Jan 15, 2019	SELL	$278.5 - $352.75 $179,911 - $227,876	-646 Closed	0 $0
Q3 2018 Oct 09, 2018	BUY	$293.51 - $383.83 $189,607 - $247,954	646 New	646 $228,000
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $164,142 - $232,151	-631 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$307.64 - $344.58 $194,120 - $217,429	631	631 $201,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.